Zaloguj się

Gotowe bibliografie tematyczne / Chemotherapy / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Chemotherapy.

Artykuły w czasopismach na temat „Chemotherapy”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 25 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Chemotherapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Armini, Ni ketut alit, Masfin Muhayanah, and Aria Nastiti. "DIARRHEA INCIDENT IN CERVICAL CANCER PATIENTS POST CHEMOTHERAPY TREATMENT." Jurnal NERS 11, no. 1 (2016): 106. http://dx.doi.org/10.20473/jn.v11i12016.106-111.

Pełny tekst źródła

Streszczenie:

Backgrounds : Cervical cancer is second most diseases suffered by women. Chemotherapy is primary treatment for cervical cancer. Chemotherpy has some side effect, and one of them is diarrhea. Diarrhea make cervical cancer suffered more. The purpose of this research was to analyze the correlation of factor’s that cause diarrhea on cervical cancer.Methods : This research uses descriptive analitic method with retrospective design. The population in this research is all patients who had post first chemotherapy. Sample in this study were 21 respondents, with purposive sampling. Variable independent

Style APA, Harvard, Vancouver, ISO itp.

2

Armini, Ni ketut alit, Masfin Muhayanah, and Aria Nastiti. "The Incident of Diarrhea among Cervical Cancer Patients Post Chemoterapy Treatment." Jurnal Ners 11, no. 1 (2016): 106–11. http://dx.doi.org/10.20473/jn.v11i1.1357.

Pełny tekst źródła

Streszczenie:

Backgrounds : Cervical cancer is second most diseases suffered by women. Chemotherapy is primary treatment for cervical cancer. Chemotherpy has some side effect, and one of them is diarrhea. Diarrhea make cervical cancer suffered more. The purpose of this research was to analyze the correlation of factor’s that cause diarrhea on cervical cancer.Methods : This research uses descriptive analitic method with retrospective design. The population in this research is all patients who had post first chemotherapy. Sample in this study were 21 respondents, with purposive sampling. Variable independent

Style APA, Harvard, Vancouver, ISO itp.

3

Akl, Maher Monir. "Glucosodiene: Opening a New Branch of Chemotherapic Sciences Called Toxinutromedicanical-Chemotherapy." Cell & Cellular Life Sciences Journal 8, no. 2 (2023): 1–2. http://dx.doi.org/10.23880/cclsj-16000185.

Pełny tekst źródła

Streszczenie:

Chemotherapy is a widely employed treatment modality in the fight against cancer aiming to eliminate both normal and cancerous cells. However, its non-discriminatory nature leads to severe side effects

Style APA, Harvard, Vancouver, ISO itp.

4

Rahiman K, Jassim. "Chemotherapy-Induced Neurotoxicity." International Journal of Science and Research (IJSR) 13, no. 8 (2024): 1250–54. http://dx.doi.org/10.21275/sr24820170848.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Dougherty, Lisa. "Practical Chemotherapy Practical Chemotherapy." Nursing Standard 17, no. 41 (2003): 29. http://dx.doi.org/10.7748/ns2003.06.17.41.29.b333.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Fitrianingsih, Nining. "HUBUNGAN TINGKAT PENGETAHUAN PERAWAT TENTANG KEMOTERAPI DENGAN TINDAKAN PEMBERIAN KEMOTERAPI PADA PASIEN KANKER PARU." Jurnal Persatuan Perawat Nasional Indonesia (JPPNI) 1, no. 3 (2017): 207. http://dx.doi.org/10.32419/jppni.v1i3.31.

Pełny tekst źródła

Streszczenie:

ABSTRAKLatar Belakang: Kemoterapi merupakan salah satu cara pengobatan kanker dengan memberikanobat atau zat yang berkhasiat membunuh sel kanker. Dalam tindakan medis, perawat harusmemiliki pengetahuan tentang prosedur pemberian obat kemoterapi karena pemberian kemoterapiyang dilakukan oleh perawat rentan terkena pada kulit atau mata pada saat melakukan tindakan.Tujuan Penelitian: mengetahui hubungan tingkat pengetahuan perawat tentang kemoterapidengan tindakan pemberian kemoterapi pada pasien kanker paru. Metode: Desain penelitianyang digunakan ialah analisis korelasional dengan pendekatan cr

Style APA, Harvard, Vancouver, ISO itp.

7

Winata, I. Gde Sastra GdeSastra. "Neoadjuvant Chemotherapy In Stadium Ib3, Iia2 And Iib Cervical Cancer." Andalas Obstetrics And Gynecology Journal 7, no. 1 (2023): 214–24. http://dx.doi.org/10.25077/aoj.7.1.214-224.2023.

Pełny tekst źródła

Streszczenie:

Aim:Â This studyÂ aimed to describe Paclitaxel-Carboplatin chemotherapy as neoadjuvant chemotherapy in stage IB3, IIA2 and IIB cervical cancer.Â Materials and Methods:Â The review was conducted by collecting journals from previous studies discussing neoadjuvant chemotherapy in cervical cancer stages IB3, IIA2, and IIB and in this case specifically discussing Paclitaxel-Carboplatin chemotherapy.Â Results:Â Neoadjuvan chemotherapy refers to systemic therapy intended to reduce the size of the tumor before the definitive operation. Several studies have shown that neoadjuvant chemotherapy has great

Style APA, Harvard, Vancouver, ISO itp.

8

Chung, Fu-Tsai, Ming-Yun Ho, Yueh-Fu Fang, et al. "The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on DifferentEGFRMutation Lung Adenocarcinoma." BioMed Research International 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/948267.

Pełny tekst źródła

Streszczenie:

Objectives. Chemotherapy as first-/second-line treatment in different epidermal growth factor receptor (EGFR) mutation lung adenocarcinoma remains controversial.Methods. Consecutive patients were collected between 2009 and 2012. Patients were divided into two groups (1st-line chemotherapy:n= 56 and 2nd-line chemotherapy:n= 55). Their outcomes profiles were analyzed.Results. The overall survival (OS) of all patients (390 versus 662 days,p< 0.0001), as well as both progression-free survival (PFS, 151 versus 252 days,p= 0.0001) and OS (308 versus 704 days,p= 0.0001) of patients withL858Rmutati

Style APA, Harvard, Vancouver, ISO itp.

9

Friedrich, Michael, Alexander Khudyakov, Arne Terjung, Wolfgang Zinn, and Ulrich Füllers. "Influence of hyperthermic intraperitoneal chemotherapy (HIPEC) on the onset of adjuvant chemotherapy in ovarian cancer." Voprosy ginekologii, akušerstva i perinatologii 21, no. 2 (2022): 14–17. http://dx.doi.org/10.20953/1726-1678-2022-2-14-17.

Pełny tekst źródła

Streszczenie:

Objective. To determine the benefits of intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced ovarian cancer. Patients and methods. The study included 87 patients, while 74 patients had epithelial ovarian cancer and 13 patients showed other neoplasms. At the end of the operation, a 1-hour perfusion of the abdominal cavity was performed with cisplatin 50 mg/m2 at a temperature of 41°C. The patient data was retrospectively analyzed considering the time interval of postoperative chemotherapy based on the guideline. Results. Sixty patients manifested macrosc

Style APA, Harvard, Vancouver, ISO itp.

10

S., Karthik, Seenivasan P., and Rajanandh M.G. "Pattern of Chemotherapy Induced Alopecia." Indian Journal of Cancer Education and Research 4, no. 2 (2016): 45–47. http://dx.doi.org/10.21088/ijcer.2321.9815.4216.1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Lucas, Amalorpavamari, Abijah Princy B, Latha Gracelin P, Merlin Nancy Deepa W, and Shiny Angel S. "Symptom Distress and Chemotherapy Induced Nausea, Vomiting and Retching (CINVR) among Cancer Patients undergoing Chemotherapy." International Journal of Science and Research (IJSR) 10, no. 7 (2021): 503–6. https://doi.org/10.21275/sr21709082808.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Loredo, Felipe Pereira de, Sabrina Ramos Bianco, Sildomar Queiroz e. Silva, and Daniella Paula Dias Coelho. "Comparison between tomosynthesis and breast magnetic resonance imaging to assess tumor response after neoadjuvant chemotherapy: a case report." Núcleo do Conhecimento 12, no. 07 (2021): 56–65. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/neoadjuvant-chemotherapy.

Pełny tekst źródła

Streszczenie:

Increasingly, the surgical treatment of breast cancer has been preserving as much tissue as possible, avoiding mutilating surgeries such as mastectomies. Therefore, it is necessary to analyze the morphological characteristics, location and size of the tumor, and neoadjuvant chemotherapy is often used to reduce the tumor mass and thus enable conservative surgery. The evaluation of tumor response to neoadjuvant chemotherapy has magnetic resonance imaging as the gold standard, which, however, is not always accessible, has a high cost and is contraindicated for claustrophobic and obese patients. T

Style APA, Harvard, Vancouver, ISO itp.

13

David, Ortiz Ciruela, López Andreu Aitana, Madrazo González Zoilo, and Rebassa Torrens María. "Chemotherapy-Associated Pneumatosis Intestinalis." International Journal of Clinical Science and Medical Research 04, no. 10 (2024): 374–75. https://doi.org/10.5281/zenodo.13985228.

Pełny tekst źródła

Streszczenie:

Abstract A 65-year-old woman underwent surgery for squamous cell carcinoma of the left tonsil (pT2pN1M0) requiring adjuvant radiotherapy and chemotherapy (cisplatin). After the second cycle of chemotherapy, the patient arrived at the Emergency Department complaining of dysphagia, dyspnoea, and cervical subcutaneous emphysema, with unremarkable abdominal examination and laboratory tests. Contrast- <strong><em> </em></strong>enhanced cervico-thoraco-abdominal CT scan with oral and intravenous contrast (fig. 1 and 2) revealed cervical and thoracic subcutaneous emphysema, pneumomediastinum, p

Style APA, Harvard, Vancouver, ISO itp.

14

Takahashi, M. "Chemotherapy." Nihon Kikan Shokudoka Gakkai Kaiho 72, no. 2 (2021): 93–96. http://dx.doi.org/10.2468/jbes.72.93.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Deasy, Michael J. "Chemotherapy." Dental Clinics of North America 34, no. 1 (1990): 1–11. http://dx.doi.org/10.1016/s0011-8532(22)01158-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Engelking, Constance. "Chemotherapy." American Journal of Nursing 87, no. 11 (1987): 1438. http://dx.doi.org/10.2307/3425898.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Pope, Robert. "Chemotherapy." Academic Medicine 92, no. 1 (2017): 76. http://dx.doi.org/10.1097/acm.0000000000001492.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Smith, Dorothy B. "Chemotherapy." Journal of Wound, Ostomy and Continence Nursing 15, no. 3 (1988): 138–39. http://dx.doi.org/10.1097/00152192-198805000-00024.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Gordon, Philip H. "Chemotherapy." Diseases of the Colon & Rectum 61, no. 3 (2018): 275–78. http://dx.doi.org/10.1097/dcr.0000000000001040.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Grajny, Agatha E., Donna Christie, Anna M. Tichy, and Marie L. Talashek. "Chemotherapy." Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional 11, no. 5 (1993): 51–58. http://dx.doi.org/10.1097/00004045-199309000-00009.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

OMURA, G. A. "Chemotherapy." JNCI Journal of the National Cancer Institute 84, no. 19 (1992): 1532–33. http://dx.doi.org/10.1093/jnci/84.19.1532-a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Kozlowski, James M. "Chemotherapy." Journal of Urology 147, no. 3 Part 2 (1992): 938–41. http://dx.doi.org/10.1016/s0022-5347(17)37428-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Terry, Anna R., and Scott R. Plotkin. "Chemotherapy:." Otolaryngologic Clinics of North America 45, no. 2 (2012): 471–86. http://dx.doi.org/10.1016/j.otc.2011.12.013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Pinedo, Herbert M., and Giuseppe Giaccone. "Chemotherapy." Lancet 349 (May 1997): S7—S9. http://dx.doi.org/10.1016/s0140-6736(97)90012-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Canter, Robert J. "Chemotherapy." Surgical Oncology Clinics of North America 25, no. 4 (2016): 861–72. http://dx.doi.org/10.1016/j.soc.2016.05.013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Needleman, Richard. "Chemotherapy." AAOHN Journal 35, no. 4 (1987): 179–82. http://dx.doi.org/10.1177/216507998703500408.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Lewis, Brian J. "Chemotherapy." International Journal of Radiation Oncology*Biology*Physics 17 (January 1989): 106. http://dx.doi.org/10.1016/0360-3016(89)90618-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Arnold, R., A. Rinke, Ch Schmidt, and L. Hofbauer. "Chemotherapy." Best Practice & Research Clinical Gastroenterology 19, no. 4 (2005): 649–56. http://dx.doi.org/10.1016/j.bpg.2005.04.004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Sugerman, Deborah Tolmach. "Chemotherapy." JAMA 310, no. 2 (2013): 218. http://dx.doi.org/10.1001/jama.2013.5525.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Grunberger, Aimée. "Chemotherapy." JAMA: The Journal of the American Medical Association 273, no. 7 (1995): 534b. http://dx.doi.org/10.1001/jama.1995.03520310030024.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Rousseau, Paul. "Chemotherapy." JAMA 298, no. 6 (2007): 604. http://dx.doi.org/10.1001/jama.298.6.604.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Li, Yiu-Tai, Szu-Ting Yang, and Peng-Hui Wang. "Chemotherapy adjuvant and chemotherapy-induced neutropenia." Taiwanese Journal of Obstetrics and Gynecology 61, no. 4 (2022): 573–74. http://dx.doi.org/10.1016/j.tjog.2022.05.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Ernani, Vinicius. "Nasopharyngeal Carcinoma: Chemotherapy or No Chemotherapy?" Journal of Oncology Practice 14, no. 10 (2018): 607–8. http://dx.doi.org/10.1200/jop.18.00532.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Henderson, Craig. "Chemotherapy treatments: chemotherapy for breast cancer." International Journal of Radiation Oncology*Biology*Physics 24 (January 1992): 93–94. http://dx.doi.org/10.1016/0360-3016(92)90075-s.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Middleton, Justin, Daniel Stover, and Tsonwin Hai. "Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response." International Journal of Molecular Sciences 19, no. 11 (2018): 3333. http://dx.doi.org/10.3390/ijms19113333.

Pełny tekst źródła

Streszczenie:

An emerging picture in cancer biology is that, paradoxically, chemotherapy can actively induce changes that favor cancer progression. These pro-cancer changes can be either inside (intrinsic) or outside (extrinsic) the cancer cells. In this review, we will discuss the extrinsic pro-cancer effect of chemotherapy; that is, the effect of chemotherapy on the non-cancer host cells to promote cancer progression. We will focus on metastasis, and will first discuss recent data from mouse models of breast cancer. Despite reducing the size of primary tumors, chemotherapy changes the tumor microenvironme

Style APA, Harvard, Vancouver, ISO itp.

36

Derks, Jules L., Robert Jan van Suylen, Erik Thunnissen, et al. "Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?" European Respiratory Journal 49, no. 6 (2017): 1601838. http://dx.doi.org/10.1183/13993003.01838-2016.

Pełny tekst źródła

Streszczenie:

Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ranges from small cell lung carcinoma (SCLC) regimens to nonsmall cell lung carcinoma (NSCLC) chemotherapy regimens. We analysed outcomes of chemotherapy treatments for LCNEC.The Netherlands Cancer Registry and Netherlands Pathology Registry (PALGA) were searched for patients with stage IV chemotherapy-treated LCNEC (2003–2012). For 207 patients, histology slides were available for pathology panel review. First-line platinum-based combined chemotherapy was clustered as “NSCLC-t”, comprising gemcita

Style APA, Harvard, Vancouver, ISO itp.

37

(R.T), Dr C. S. K. Prakash, M. D. "Nasopharyngeal Carcinoma- Role of External Beam Radiotherapy (EBRT) and Chemotherapy Vs EBRT, Chemotherapy and Intraluminal Brachytherapy." Journal of Medical Science And clinical Research 04, no. 10 (2016): 13348–61. http://dx.doi.org/10.18535/jmscr/v4i10.92.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Moha, Rico. "Chemotherapy medication of Vincristine and Vinblastine." Cancer Research and Cellular Therapeutics 1, no. 1 (2017): 01–02. http://dx.doi.org/10.31579/2640-1053/007.

Pełny tekst źródła

Streszczenie:

Cancers treated with Vincristine and vinblastine include: acute leukemia, Hodgkin's and non- Hodgkin's lymphoma, neuroblastoma, rhabdomyosarcoma, Ewing's sarcoma, Wilms' tumor, multiple myeloma, chronic leukemias, thyroid cancer, brain tumors, non-small cell lung cancer, bladder cancer, melanoma, and testicular cancer andIt is also used to treat some blood disorders. It is given by injection into a vein. Vincristine and vinblastine exhibit differential activity against tumors and normal tissues. In this work, a number of cultured cell lines were assayed for their sensitivity to the antiprolife

Style APA, Harvard, Vancouver, ISO itp.

39

Yamashita, Tatsuya. "Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?" Journal of Gastroenterology 39, no. 4 (2004): 404–6. http://dx.doi.org/10.1007/s00535-004-1330-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Ardhiansyah, Azril Okta, IB Tjakra Wibawa Manuaba, and I. Ketut Widiana. "Post-Chemotherapy Monocytopenia as a Predictor of Chemotherapy – Induced Neutropenia in Breast Cancer Patients." Bali Medical Journal 11, no. 3 (2022): 1325–30. http://dx.doi.org/10.15562/bmj.v11i3.2844.

Pełny tekst źródła

Streszczenie:

Background: Chemotherapy-induced neutropenia (CIN) is chemotherapy's most frequent myelosuppression effect. Previous studies have examined static prognostic factors to assess dynamic neutrophil changes in each cycle. This study focuses on post-chemotherapy monocytopenia as a more dynamic predictor of CIN. This research aimed to know whether post-chemotherapy monocytopenia can be used as a predictor of CIN in breast cancer patients undergoing the chemotherapy cycle. Methods: This research used a prospective and a retrospective longitudinal cohort of breast cancer patients undergo a CAF regimen

Style APA, Harvard, Vancouver, ISO itp.

41

Cai, Runkai, Jianwei Zhang, Yue Cai, et al. "Adjuvant chemotherapy in ypStage III locally advanced rectal cancer after neoadjuvant treatment with an oxaliplatin-based regimen." Journal of Clinical Oncology 41, no. 16_suppl (2023): e15628-e15628. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15628.

Pełny tekst źródła

Streszczenie:

e15628 Background: Fluorouracil -based neoadjuvant chemoradiotherapy(CRT) followed by total mesorectal excision and adjuvant chemotherapy is the standard treatment for locally advanced rectal cancer (LARC). Adjvuant FOLFOX improved survival benefit compared with fluorouracil in patients with ypStage II andIII after CRT. However, induction or consolidation chemotherapy with FOLFOX before surgery had been the new standard for LARC. Whether adjuvant chemotherapy with FOLFOX still improves survival outcomes in ypStage III patients previously exposed to oxaliplatin-based treatment was unknwon. Meth

Style APA, Harvard, Vancouver, ISO itp.

42

Raval, Vishal, R. Christopher Bowen, Hansell Soto, and Arun Singh. "Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy." Asia-Pacific Journal of Ophthalmology 10, no. 2 (2020): 200–202. http://dx.doi.org/10.1097/apo.0000000000000322.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Spellman, E., and A. Page. "Chemotherapy information cards for staff administering chemotherapy." European Journal of Cancer 37 (April 2001): S412. http://dx.doi.org/10.1016/s0959-8049(01)81969-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Rosell, R., M. Taron, A. Vergnenegre, et al. "38IN CHEMOTHERAPY SELECTION ACCORDING TO CHEMOTHERAPY BIOMARKERS." Lung Cancer 71 (February 2011): S22—S23. http://dx.doi.org/10.1016/s0169-5002(11)70175-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Schorge, John O. "Chemotherapy-free, but not quite free chemotherapy." Lancet Oncology 20, no. 10 (2019): 1335–37. http://dx.doi.org/10.1016/s1470-2045(19)30492-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Ando, Yuichi, Akiko Ota, and Rie Tsuboi. "Introduction of chemotherapy (Molecular targeting agent・Chemotherapy)." Toukeibu Gan 42, no. 3 (2016): 309–15. http://dx.doi.org/10.5981/jjhnc.42.309.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Sun, Danyang, Junxun Ma, Jinliang Wang, et al. "Anti-PD-1 therapy combined with chemotherapy in patients with advanced pancreas cancer in a real-world clinical setting." Journal of Clinical Oncology 37, no. 15_suppl (2019): e14103-e14103. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14103.

Pełny tekst źródła

Streszczenie:

e14103 Background: Pancreatic cancer (PC) is a highly lethal disease and characterized by a strong resistance to current radiotherapy and chemotherapy. As PC has the presence of a microenvironment filled with immunosuppressive mediators and a dense stroma which involved in immune system control, the immune system has been hypothesized to play an important role in PC. However, there was no response in patients who received immune checkpoint inhibitors (ICIs) monotherapy. Though small sample studies revealed that ICIs combined with chemotherapy is effective, a head-to-head comparison of ICIs plu

Style APA, Harvard, Vancouver, ISO itp.

48

Indriastuti, Endah, Endang Retnowati, and Wita Saraswati. "CD4-T LYMPHOCYTE IN CERVICAL CANCER PATIENTS ON PRE- AND POST CHEMOTHERAPY." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 26, no. 1 (2019): 30. http://dx.doi.org/10.24293/ijcpml.v26i1.1367.

Pełny tekst źródła

Streszczenie:

Introduction : Cervical cancer is a gynecology cancer with the highest incidence in the Dr.Soetomo Hospital, Surabaya. Neoadjuvant chemotherapy with cisplatin has been used to increase radiosensitivy of cancer cells before radiotherapy done in advanced stage cervical cancer patients. This research aimed to know the differences of CD4-T lymphocyte profile in stage IIIB patient before and after chemotheraphy administration.Methods : This research was done in February-September 2018. Seventeen patients out of 31 stage IIIB cervical cancer patients planned to receive neoadjuvan chemotherapy with c

Style APA, Harvard, Vancouver, ISO itp.

49

Tusan Sidharta, I. Made, I. Ketut Siki Kawiyana, and I. Ketut Suyasa. "Lymphocyte-monocyte ratio as predictive factors for huvos scores in osteosarcoma extremities treated by neoadjuvan chemotherapy (cisplatin and doxorubicin)." International Journal of Research in Medical Sciences 8, no. 11 (2020): 3816. http://dx.doi.org/10.18203/2320-6012.ijrms20204863.

Pełny tekst źródła

Streszczenie:

Background: Chemotherapy is a vital treatment in osteosarcoma but it’s responses are difficult to predict, and there are still no biomarkers that can estimate the prognosis of chemotherapy. Lymphocytes and monocytes are key immune cells which are examined on complete blood count test before chemotherapy and often associated with prognosis of various malignancies. Low lymphocyte-monocyte ratio (LMR) are associated with poor prognostics in some cancers.Methods: This study is cross-sectional retrospective analytics that was conducted at Sanglah Hospital from June to August 2018. The research subj

Style APA, Harvard, Vancouver, ISO itp.

50

Sugo, Maria Evarista, Tiyas Kusumaningrum, and Rista Fauziningtyas. "Faktor Strategi Koping pada Pasien Kanker yang Menjalani Kemoterapi." Pediomaternal Nursing Journal 5, no. 1 (2019): 99. http://dx.doi.org/10.20473/pmnj.v5i1.12459.

Pełny tekst źródła

Streszczenie:

Introduction: Chemotherapy is one of the treatments for cancer that is effective and requires a considerable amount of time so that an adaptive coping strategy is needed from the patient. Patient coping strategies can be influenced by physical, psychological, and social factors. The purpose of this study was to analyze the factors associated with coping strategies for cancer patients undergoing chemotherapy at Prof. W Z Johannes Kupang Hospital.Methods: The design in this study was cross-sectional. The total population were 163 and obtained 100 respondents by consequtive sampling. Independent

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!